Skip to main content
Premium Trial:

Request an Annual Quote

CEO Loans Pressure BioSciences $100K

NEW YORK (GenomeWeb News) – Pressure BioSciences has received a $100,000 loan from its CEO, the company disclosed in a document filed with the US Securities and Exchange Commission today.

The loan from Richard Schumacher has a maturity date of Nov. 5 and can be extended by mutual agreement of both parties. It carries an annual interest rate of 20 percent.

In connection with the loan, Pressure Bio issued Schumacher a warrant to purchase 12,048 shares of the company's stock at an exercise price of $.83 per share. The warrant expires on Sept. 7, 2014.

The company also said that on Sept. 2 it issued an aggregate of 124,996 shares of its common stock to its independent directors in payment for all board fees. The number of shares issued was based on $.84 per share, which was the greater of the consolidated bid or the closing price of Pressure Bio's stock on Sept. 1.

Last month, the South Easton, Mass.-based firm said that its second-quarter revenues dropped 53 percent year over year and that it had enough capital to last only until the middle of September. Earlier this week it received a $161,000 SBIR grant from the National Institute of General Medical Sciences.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.